Bavarian Nordic A/S sell WatchMen
Start price
27.03.24
/
50%
€19.94
Target price
-
Performance (%)
-
End price
27.03.24
-
Summary
This prediction was cancelled by the user.Bavarian Nordic (symbol: BAVA) is a biotechnology company that specializes in developing innovative vaccines for serious diseases such as cancer and infectious diseases like Ebola and COVID-19. The company has a broad portfolio of vaccines that are under development and has collaboration agreements with various pharmaceutical companies and government agencies. Bavarian Nordic's flagship product is its cancer vaccine known as PROSTVAC, which is currently undergoing clinical trials for the treatment of prostate cancer. The company is listed on the NASDAQ Copenhagen stock exchange and has a market capitalization of approximately $925 million as of May 2021.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bavarian Nordic A/S | 2.021% | 2.021% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by WatchMen for this prediction
In the thread Bavarian Nordic A/S diskutieren
Sell Bavarian Nordic A/S